即将上市的寨卡病毒疫苗对先天性寨卡综合征影响与成本效益的建模研究
研究构建基于个体的房室模型,模拟新加坡未来十年寨卡病毒疫情轨迹与先天性寨卡综合征(CZS)疾病负担,并评估8种针对育龄女性的疫苗接种策略的成本效益。结果显示持续输入可致多次小规模暴发,不同既往免疫水平下CZS病例数不同,孕前接种策略在多种情景下均具成本效益。
要点
- 未来十年CZS病例数在既往免疫0%、2%、5%情景下分别为68、51、32例。
- 大规模接种可为育龄女性分别避免最多66、49、31例CZS病例。
- 孕前接种策略不受疫苗保护时长、效力、价格或既往免疫水平影响,始终具成本效益。
核心结论
- 新加坡由输入驱动的局部暴发可能持续存在。
- 孕前接种策略始终具成本效益,应考虑采用。
- 若可获得低成本且提供长期保护的疫苗,大规模接种也可能可行。
研究设计与样本
- 研究建立基于个体的房室模型,纳入新加坡人口动态,模拟寨卡病毒疫情轨迹并预测未来十年全国CZS疾病负担。
- 提出8种针对育龄女性的疫苗接种策略,在不同疫苗效力、保护时长、覆盖率、接种成本和人群既往免疫水平情景下评估增量成本效果比(ICER)。
主要发现
- 未来十年CZS总病例数在既往免疫0%、2%、5%情景下分别为68例(95%CI:66-70)、51例(95%CI:49-52)和32例(95%CI:31-33)。
- 大规模接种育龄女性在上述三种情景下分别避免最多66例(95%CI:64-69)、49例(95%CI:48-50)和31例(95%CI:30-31)CZS病例。
- 这些策略的成本效益需逐案评估。
- 孕前接种策略无论疫苗保护时长、疫苗效力、疫苗价格或人群既往免疫水平如何,均显示一致的cost-effectiveness。
临床怎么用
- 作者认为孕前接种策略始终具成本效益,应考虑采用。
- 作者认为若可获得低成本且提供长期保护的疫苗,大规模接种也可能可行。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Zika virus (ZIKV) continues to circulate in Southeast Asia following the 2015-2016 global epidemic, posing an ongoing risk of importation and disease spread for Singapore, a tropical city-state in the region. The virus remains a threat to pregnant women and their fetuses due to the risk of Congenital Zika Syndrome (CZS). Vaccines currently in development offer hope for reducing ZIKV infections and CZS cases. METHODS: We developed an agent-based compartmental model, incorporating Singapore's demographic dynamics, to simulate ZIKV epidemic trajectories and project the national disease burden of CZS over the next decade. We proposed eight vaccination strategies targeting females of child-bearing age and evaluated their cost-effectiveness-in terms of the incremental cost-effectiveness ratio (ICER)-across scenarios with varying vaccine efficacy, protection duration, coverage rate, vaccination cost, and pre-existing immunity levels in the population. RESULTS: Continuous high importation of ZIKV could lead to multiple small outbreaks in the next decade. Total CZS case numbers over the next decade were projected to be 68 (95 % confidence interval [CI]: 66-70), 51 (95 % CI: 49-52), and 32 (95 % CI: 31-33) under scenarios of 0 %, 2 %, and 5 % pre-existing immunity, respectively. While mass vaccination for females would avert up to 66 (95 % CI: 64-69), 49 (95 % CI: 48-50), and 31 (95 % CI: 30-31) CZS cases, respectively, the cost-effectiveness of these strategies should be evaluated on a case-by-case basis. The pre-pregnancy vaccination strategy demonstrated consistent cost-effectiveness regardless of vaccine protection duration, vaccine efficacy, vaccine price, or pre-existing immunity level in the population. CONCLUSIONS: Localised outbreaks driven by importation are likely to persist in Singapore. The pre-pregnancy vaccination strategy is consistently cost-effective and should be considered. Mass vaccination may also be viable with the availability of a low-cost vaccine providing long-term protection.
引用
- Song H, Jin S, Yang GJ, et al. Modelling the impact and cost-effectiveness of upcoming Zika virus vaccines on congenital Zika syndrome. Vaccine. 2025. PMID: 39823847. doi:10.1016/j.vaccine.2025.126728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。